Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

被引:126
作者
Nordeng, H [1 ]
Lindemann, R
Perminov, KV
Reikvam, Å
机构
[1] Ulleval Univ Hosp, Dept Pharmacotherapeut, N-0407 Oslo, Norway
[2] Ulleval Univ Hosp, Neonatal Intens Care Unit, Oslo, Norway
[3] Ulleval Univ Hosp, Dept Paediat, Oslo, Norway
[4] Cent Hosp Akershus, Dept Paediat, Neonatal Intens Care Unit, Nordbyhagen, Norway
关键词
antidepressants; in utero exposure; neonatal withdrawal syndrome; selective serotonin reuptake inhibitors; SSRI;
D O I
10.1080/080352501300067596
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Selective serotonin reuptake inhibitors (SSRIs) are a new group of antidepressants used in mild to moderate cases of depression. In studies evaluating the safety of SSRIs during pregnancy, no increase in major anomalies has been reported. This might have led to increasing off-label prescription of SSRIs to pregnant women. Neonatal withdrawal syndrome commonly occurs in infants exposed during the third trimester to drugs known to cause addiction. We report five cases of neonatal withdrawal syndrome after third trimester in utero SSRI exposure. In three cases the mother used paroxetine in doses from 10 to 40 mg, one mother used citalopram 30 mg, and one mother fluoxetine 20 mg. Withdrawal symptoms occurred within few days after birth and lasted up to one month after birth. Four of the infants needed treatment with chlorpromazine. Symptoms were irritability, constant crying, shivering. increased tonus, eating and sleeping difficulties and convulsions. Conclusion: Neonatal withdrawal syndrome can occur after third trimester in utero SSRI exposure. Further research should focus on whether it is safe to use SSRIs during the last trimester. All neonates exposed to SSRIs during the last trimester should be followed-up closely for withdrawal symptoms after birth.
引用
收藏
页码:288 / 291
页数:4
相关论文
共 12 条
  • [1] Berlin CM, 1998, PEDIATRICS, V101, P1079
  • [2] Birth outcomes in pregnant women taking fluoxetine
    Chambers, CD
    Johnson, KA
    Dick, LM
    Felix, RJ
    Jones, KL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1010 - 1015
  • [3] NEONATAL CONVULSIONS CAUSED BY WITHDRAWAL FROM MATERNAL CLOMIPRAMINE
    COWE, L
    LLOYD, DJ
    DAWLING, S
    [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6332) : 1837 - 1838
  • [4] Paroxetine withdrawal syndrome in a neonate
    Dahl, ML
    Olhager, E
    Ahlner, J
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 391 - 392
  • [5] SUSPECTED CONGENITAL SERTRALINE DEPENDENCE
    KENT, LSW
    LAIDLAW, DD
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 : 412 - 413
  • [6] Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors - A prospective controlled multicenter study
    Kulin, NA
    Pastuszak, A
    Sage, SR
    Schick-Boschetto, B
    Spivey, G
    Feldkamp, M
    Ormond, K
    Matsui, D
    Stein-Schechman, AK
    Cook, L
    Brochu, J
    Rieder, M
    Koren, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (08): : 609 - 610
  • [7] NEONATAL WITHDRAWAL SYMPTOMS AFTER CHRONIC MATERNAL INGESTION OF CAFFEINE
    MCGOWAN, JD
    ALTMAN, RE
    KANTO, WP
    [J]. SOUTHERN MEDICAL JOURNAL, 1988, 81 (09) : 1092 - 1094
  • [8] Potential fluoxetine chloride (Prozac) toxicity in a newborn
    Mhanna, MJ
    Bennet, JB
    Izatt, SD
    [J]. PEDIATRICS, 1997, 100 (01) : 158 - 159
  • [9] PREGNANCY OUTCOME FOLLOWING 1ST-TRIMESTER EXPOSURE TO FLUOXETINE (PROZAC)
    PASTUSZAK, A
    SCHICKBOSCHETTO, B
    ZUBER, C
    FELDKAMP, M
    PINELLI, M
    SIHN, S
    DONNENFELD, A
    MCCORMACK, M
    LEENMITCHELL, M
    WOODLAND, C
    GARDNER, A
    HORN, M
    KOREN, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (17): : 2246 - 2248
  • [10] ROUTLEDGE PA, 1997, ADVERSE DRUG REACT B, V187, P711